Cargando…
Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer
Acquired resistance to chemotherapy is a major limitation in clinical treatment for breast cancer. Accumulating evidence from in vitro, in vivo and clinical studies suggest that acquired chemoresistance is progressive, multifactorial and involve genetic and epigenetic aberrations. Among various mech...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992622/ https://www.ncbi.nlm.nih.gov/pubmed/35582717 http://dx.doi.org/10.20517/cdr.2018.11 |